Please click on the following links to get information on  Pradaxa®  (dabigatran etexilate) Prescriber Guide for primary prevention of venous thromboembolic events (VTE) following elective total hip or knee replacement surgery together with the Pradaxa®  (dabigatran etexilate) Prescriber Guide for stroke prevention in atrial fibrillation, treatment of deep vein thrombosis (DVT) , pulmonary embolism (PE), and the prevention of recurrent DVT and PE in adults (DVT/PE). 

This information is being distributed as part of the Risk Management Plan for Pradaxa®  (dabigatran etexilate) on behalf of Boehringer Ingelheim.